Showing results (1-10 of 64) with videos related to
Sort By:
Pageof 7
Expert Opinion on Drug Metabolism & Toxicology|May 24, 2011
Pharmacokinetic evaluation of pemetrexedJens Benn SørensenThe Clinical Respiratory Journal|March 20, 2010
Current concepts in chemotherapy for malignant pleural mesotheliomaJens Benn SørensenJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Polyneuropathy in a patient with malignant pleural mesothelioma: a paraneoplastic syndromeCecilia Bech, Jens Benn SørensenEuropean Respiratory Review : an Official Journal of the European Respiratory Society|June 2, 2015
Biomarkers for efficacy of adjuvant chemotherapy following complete resection in NSCLC stages I-IIIASandra Wallerek, Jens Benn SørensenJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2010
Chemotherapy induced pathologic complete response in malignant pleural mesothelioma: a review and case reportCecilia Bech, Jens Benn SørensenLung Cancer (Amsterdam, Netherlands)|September 23, 2008
Excision repair cross-complementation group 1 (ERCC1) in platinum-based treatment of non-small cell lung cancer with special emphasis on carboplatin: a review of current literatureAdam Vilmar, Jens Benn SørensenThe Journal of Supportive Oncology|June 17, 2008
Outpatient management of febrile neutropenia: time to revise the present treatment strategyMads Carstensen, Jens Benn SørensenAnticancer Research|October 28, 2015
Platinum-Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLCLinda Michelsen, Jens Benn SørensenThoracic Surgery Clinics|April 23, 2015
Long-term Oncologic and financial implications of lung cancer screeningJesper Holst Pedersen, Jens Benn SørensenLung Cancer (Amsterdam, Netherlands)|November 10, 2012
Clinical impact of ki-67 labeling index in non-small cell lung cancerJan Nyrop Jakobsen, Jens Benn SørensenPageof 7